Your browser is no longer supported. Please, upgrade your browser.
Settings
NOVN Novan, Inc. daily Stock Chart
NOVN [NASD]
Novan, Inc.
Index- P/E- EPS (ttm)-2.15 Insider Own2.10% Shs Outstand15.79M Perf Week-7.60%
Market Cap71.06M Forward P/E- EPS next Y-3.60 Insider Trans0.00% Shs Float9.27M Perf Month-16.67%
Income-42.00M PEG- EPS next Q-0.56 Inst Own6.00% Short Float3.97% Perf Quarter-28.57%
Sales1.50M P/S47.37 EPS this Y-479.50% Inst Trans-3.27% Short Ratio6.70 Perf Half Y14.21%
Book/sh0.33 P/B13.64 EPS next Y-48.80% ROA-100.20% Target Price9.67 Perf Year-83.10%
Cash/sh0.70 P/C6.46 EPS next 5Y- ROE-244.40% 52W Range3.52 - 28.82 Perf YTD-83.35%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-84.32% Beta-
Dividend %- Quick Ratio1.40 Sales past 5Y- Gross Margin- 52W Low28.41% ATR0.37
Employees62 Current Ratio1.40 Sales Q/Q- Oper. Margin- RSI (14)39.90 Volatility9.29% 7.17%
OptionableYes Debt/Eq1.54 EPS Q/Q60.10% Profit Margin- Rel Volume0.89 Prev Close4.50
ShortableYes LT Debt/Eq1.54 EarningsDec 18 BMO Payout- Avg Volume54.91K Price4.52
Recom2.30 SMA20-8.76% SMA50-15.57% SMA200-12.41% Volume21,621 Change0.44%
Dec-15-17 02:00AM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Novan, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 2, 2018 - NOVN ACCESSWIRE
Dec-14-17 12:30PM  Scott+Scott, Attorneys at Law, LLP Reminds Investors of Securities Class Action Against Novan, Inc. (NOVN) and Lead Plaintiff Deadline of January 2 Business Wire
02:00AM  The Klein Law Firm Reminds Investors of a Class Action on Behalf of Novan, Inc. Shareholders and a Lead Plaintiff Deadline of January 2, 2018 (NOVN) GlobeNewswire
Dec-13-17 03:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Novan, Inc. of Class Action Lawsuit and Upcoming Deadline - NOVN ACCESSWIRE
02:45PM  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Novan, Inc. of a Lawsuit and a Lead Plaintiff Deadline of January 2, 2018 - NOVN ACCESSWIRE
Dec-12-17 05:20PM  NOVAN INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Novan, Inc. To Contact The Firm ACCESSWIRE
02:45AM  NOVN INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Novan, Inc. and a Lead Plaintiff Deadline of January 2, 2018 GlobeNewswire
Dec-11-17 03:23PM  CORRECTING and REPLACING Robbins Arroyo LLP: Novan, Inc. (NOVN) Misled Shareholders According to a Recently Filed Class Action Business Wire -11.16%
03:00PM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Novan, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 2, 2018 NOVN GlobeNewswire
02:42PM  DEADLINE ALERT: Brower Piven Reminds Investors of Upcoming Deadline in Class Action Lawsuit and Encourages Shareholders Who Have Losses in Excess of $100,000 from Investment in Novan, Inc. to Contact the Firm Business Wire
10:51AM  Novartis drug crizanlizumab shown to prolong time to patients' first sickle cell pain crisis in subgroup analysis of SUSTAIN study GlobeNewswire
10:44AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Novan, Inc. (NOVN) and Lead Plaintiff Deadline: January 2, 2018 ACCESSWIRE
Dec-10-17 10:40AM  Primary analysis results from Novartis pivotal JULIET trial show Kymriah(TM) (tisagenlecleucel) sustained complete responses at six months in adults with r/r DLBCL, a difficult-to-treat cancer GlobeNewswire
Dec-09-17 08:00AM  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Novan, Inc. of Class Action Lawsuit and Upcoming Deadline NOVN GlobeNewswire
Dec-08-17 10:50PM  NOVAN SHAREHOLDER ALERT: ClaimsFiler Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit against Novan, Inc. - (NOVN) Business Wire
01:16AM  Sandoz announces new Phase I data showing proposed biosimilar pegfilgrastim matches reference medicine GlobeNewswire
Dec-07-17 03:00PM  The Klein Law Firm Notifies Investors of a Class Action Commenced on Behalf of Novan, Inc. Shareholders and a Lead Plaintiff Deadline of January 2, 2018 (NOVN) ACCESSWIRE
Dec-06-17 06:57PM  Robbins Arroyo LLP: Novan, Inc. (NOVN) Misled Shareholders According to a Recently Filed Class Action Business Wire
01:16PM  Novartis Kisqali® is first and only CDK4/6 inhibitor to show superior median PFS compared to oral endocrine therapy as first-line treatment in a prospective, randomized Phase III trial dedicated to... GlobeNewswire
11:11AM  UnitedHealth buys DaVita for $4.9B Yahoo Finance Video
08:47AM  Stocks tread lower, Bitcoin surges to record high Yahoo Finance
Dec-05-17 05:36PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Novan, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 2, 2018 - NOVN ACCESSWIRE
04:30PM  IMPORTANT NOVAN, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Middle District of North Carolina against Novan, Inc. GlobeNewswire
08:35AM  Novan Announces First Patient Dosed in Phase 1b Atopic Dermatitis Trial with SB414 GlobeNewswire
Dec-04-17 03:10PM  NOVN EXPANDED CLASS: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Novan, Inc. and a Lead Plaintiff Deadline of January 2, 2018 ACCESSWIRE
11:32AM  Dow soars as Nasdaq struggles, Congress moves on tax bill Yahoo Finance
10:43AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Novan, Inc. (NOVN) and Lead Plaintiff Deadline: January 2, 2018 ACCESSWIRE
08:36AM  Stocks start in the green despite major tax bill concerns Yahoo Finance
Dec-02-17 10:32AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Novan, Inc. of Class Action Lawsuit and Upcoming Deadline - NOVN ACCESSWIRE
Dec-01-17 10:50PM  NOVAN SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Novan, Inc. - (NOVN) PR Newswire
03:10PM  EXPANDED CLASS: Levi & Korsinsky, LLP Notifies Shareholders of Novan, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 2, 2018 - NOVN ACCESSWIRE
12:26PM  Glancy Prongay & Murray LLP Continues Investigation on Behalf of Novan, Inc. Investors (NOVN) Business Wire
11:13AM  Amazon could make your medication a lot cheaper Yahoo Finance Video
10:43AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Novan, Inc. (NOVN) & Lead Plaintiff Deadline: January 2, 2018 ACCESSWIRE
07:20AM  Yahoo Finance Live: Market Movers - Dec 1st, 2017 Yahoo Finance Video
Nov-30-17 06:04PM  The Klein Law Firm Reminds Investors of Commencement of a Class Action Filed on Behalf of Novan, Inc. Shareholders and a Lead Plaintiff Deadline of January 2, 2018 Business Wire
05:14PM  INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Novan, Inc. (Nasdaq: NOVN) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit GlobeNewswire
01:16AM  Novartis' Cosentyx® is first biologic to show long-term efficacy in nail and palmoplantar psoriasis, which can impact up to 90% of psoriasis patients GlobeNewswire
Nov-29-17 05:01PM  Novartis announces Phase III STRIVE data published in NEJM demonstrating significant and sustained efficacy of erenumab in migraine prevention GlobeNewswire +6.37%
Nov-28-17 03:18PM  NOVN EXPANDED CLASS: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Novan, Inc. and a Lead Plaintiff Deadline of January 2, 2018 Business Wire
10:19AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Novan, Inc. (NOVN) & Lead Plaintiff Deadline: January 2, 2018 ACCESSWIRE
Nov-27-17 03:10PM  EXPANDED CLASS PERIOD: Levi & Korsinsky, LLP Reminds Shareholders of Novan, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 2, 2018 Business Wire -9.48%
02:18AM  Novartis' Ultibro® Breezhaler® significantly improved COPD patients' lung function after direct switch from Seretide® GlobeNewswire
Nov-24-17 10:50PM  NOVAN SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit against Novan, Inc. - (NOVN) Business Wire
05:15PM  Pomerantz Law Firm Announces the Filing of a Class Action against Novan, Inc. and Certain Officers NOVN GlobeNewswire
Nov-22-17 04:58PM  NOVAN INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Novan, Inc. To Contact The Firm PR Newswire
08:25AM  Novan to Present at Piper Jaffray 29th Annual Healthcare Conference GlobeNewswire
Nov-21-17 03:15PM  The Klein Law Firm Notifies Investors of Commencement of a Class Action Filed on Behalf of Novan, Inc. Shareholders and a Lead Plaintiff Deadline of January 2, 2018 Business Wire
10:19AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Novan, Inc. (NOVN) & Lead Plaintiff Deadline - January 2, 2018 ACCESSWIRE
Nov-20-17 03:15PM  The Klein Law Firm Notifies Investors of a Class Action Filed on Behalf of Novan, Inc. Shareholders and a Lead Plaintiff Deadline of January 2, 2018 (NOVN) GlobeNewswire
01:16AM  Novartis drug Tasigna® (nilotinib) secures EU approval for first and second-line treatment of Ph+ CML-CP in children GlobeNewswire
Nov-17-17 10:50PM  NOVAN SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Novan, Inc. - (NOVN) GlobeNewswire
01:53PM  NOVN SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Novan, Inc. and a Lead Plaintiff Deadline of January 2, 2018 Business Wire
10:18AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Novan, Inc. (NOVN) & Lead Plaintiff Deadline - January 2, 2018 ACCESSWIRE
06:00AM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 from Investment in Novan, Inc. to Contact Brower Piven before the Lead Plaintiff Deadline in Class Action Lawsuit Business Wire
Nov-16-17 06:17PM  Lifshitz & Miller LLP Announces Investigation of Manitex International, Inc., Novan, Inc., Ocera Therapeutics, Inc., Planet Payment, Inc., RE/MAX Holdings, Inc., Super Micro Computer, Inc. and World Acceptance Corporation PR Newswire
05:27PM  NOVAN INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Novan, Inc. To Contact The Firm GlobeNewswire
02:03PM  NOVN SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Novan, Inc. and a Lead Plaintiff Deadline of January 2, 2018 GlobeNewswire
12:06PM  Cohen Milstein Sellers & Toll PLLC Announces Investigation of Novan Inc. Business Wire
Nov-15-17 06:00PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Novan, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 2, 2018 Business Wire
01:30PM  Lawsuit for Investors in Shares of Novan Inc. (NASDAQ: NOVN) Announced by Shareholders Foundation ACCESSWIRE
09:01AM  Novartis, ASCP and ACS join forces to fight cancer in Ethiopia, Uganda and Tanzania GlobeNewswire
Nov-14-17 02:45PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Novan, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 2, 2018 NOVN GlobeNewswire
10:17AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Novan, Inc. (NOVN) & Lead Plaintiff Deadline - January 2, 2018 ACCESSWIRE
01:16AM  Novartis presents new data at SABCS across broad range of breast cancer patient populations, combination treatments and lines of therapy GlobeNewswire
01:11AM  New data reinforces clinical basis for switching to Sandoz biosimilar medicines GlobeNewswire
Nov-13-17 12:02PM  Novartis canakinumab (ACZ885) reduced cardiovascular risk by 25% in subgroup of CANTOS Phase III trial participants GlobeNewswire
01:01AM  Novartis highlights its differentiated late stage pipeline at the R&D update and investor event GlobeNewswire
Nov-12-17 09:52PM  Novartis brolucizumab (RTH258) demonstrates superiority versus aflibercept in key secondary endpoint measures of disease activity in nAMD, a leading cause of blindness GlobeNewswire
02:55PM  The Klein Law Firm Reminds Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Novan, Inc. Business Wire
01:31PM  New Novartis Entresto® real world evidence data shows beneficial impact on quality of life in people living with heart failure GlobeNewswire
Nov-11-17 08:02AM  Punjab province in Pakistan signs agreement with Novartis Access against chronic diseases GlobeNewswire
Nov-10-17 10:50PM  NOVAN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Novan, Inc. - (NOVN) PR Newswire
05:52PM  Novartis brolucizumab (RTH258) demonstrates superiority versus aflibercept in key secondary endpoint measures of disease activity in nAMD, a leading cause of blindness GlobeNewswire
04:35PM  IMPORTANT NOVAN, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Middle District of North Carolina against Novan, Inc. GlobeNewswire
01:00AM  The Klein Law Firm Notifies Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Novan, Inc. (NOVN) Business Wire
Nov-09-17 01:58PM  Scott+Scott, Attorneys at Law, LLP Alerts Investors to the Filing of a Securities Class Action Against Novan, Inc. (NOVN) PR Newswire
10:16AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Novan, Inc. (NOVN) & Lead Plaintiff Deadline - January 2, 2018 ACCESSWIRE
03:00AM  NOVN INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Novan, Inc. Business Wire
Nov-08-17 10:34AM  SHAREHOLDER ALERT:  Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Novan, Inc. (Nasdaq:NOVN) To Contact Brower Piven Before The Lead Plaintiff Deadline GlobeNewswire
02:00AM  SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Novan, Inc. Business Wire
01:16AM  Novartis reports positive results from Phase III trial of Kisqali® (ribociclib) combination therapy in premenopausal women with HR+/HER2- advanced or metastatic breast cancer GlobeNewswire
Nov-07-17 08:00PM  Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Novan, Inc. (NOVN) GlobeNewswire +5.44%
07:30PM  Robbins Geller Rudman & Dowd LLP Files Class Action Suit against Novan, Inc. Business Wire
06:30PM  RM LAW Announces Class Action Lawsuit Against Novan, Inc. PR Newswire
05:00PM  Glancy Prongay & Murray LLP Commences Investigation on Behalf of Novan, Inc. Investors (NOVN) Business Wire
03:30PM  Novan shares up on third-party financing news American City Business Journals
03:15PM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of Commencement of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Novan, Inc. Business Wire
02:05PM  NOVN INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Novan, Inc. Investors Business Wire
08:05AM  Novan Announces Plan to Complete Development of SB204 Acne Candidate via Third Party Funding and Execution GlobeNewswire
01:17AM  Novartis announces study data demonstrating Cosentyx® reduced signs and symptoms of psoriatic arthritis while inhibiting progression of joint structural damage GlobeNewswire
Nov-06-17 05:30PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novan, Inc. - NOVN PR Newswire -9.95%
05:30PM  Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Novan, Inc. (NOVN) and Encourages Investors to Contact the Firm Business Wire
04:36PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novan, Inc. - NOVN PR Newswire
02:43PM  NOVAN INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing in Novan, Inc. to Contact the Firm ACCESSWIRE
10:10AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Novan, Inc. (NOVN) & Lead Plaintiff Deadline - January 2, 2018 PR Newswire
10:07AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Novan, Inc. Business Wire
01:16AM  Novartis seeks leadership with Cosentyx® showing no radiographic progression in ankylosing spondylitis at 4 years GlobeNewswire
Nov-05-17 08:50AM  Johnson Fistel, LLP Files Class Action Suit against Novan, Inc.; Lead Plaintiff Deadline is January 2, 2018 PR Newswire
Nov-03-17 10:50PM  NOVAN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Novan, Inc. - (NOVN) GlobeNewswire
Novan, Inc., a clinical-stage drug development company, focuses on the development and commercialization of nitric oxide-based therapies in dermatology. Its lead product candidate is SB204, a cosmetically elegant topical gel that targets multiple mechanisms of action for the treatment of acne vulgaris. The company's product candidates also include SB206, SB208, and SB414, which are targeted toward the treatment of either a specific microorganism or inflammatory components of disease pathology. Novan, Inc. was founded in 2006 and is headquartered in Durham, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hodges William LInterim Chief Financial OfficeSep 15Option Exercise6.035,00030,1505,000Sep 18 04:35 PM